NYSE · Financial Statements

Elanco Animal Health Incorporated (ELAN) Financial Statements

$22.52 NYSE: ELAN Market Cap $11.25B

Elanco Animal Health Incorporated most recently reported annual revenue of $4.7B, a net loss of $232.0M. Revenue grew at an average annual rate of 7.6% over the last 5 fiscal years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Elanco Animal Health Incorporated: Revenue rose from $2.9B in 2016 to $4.7B in 2025, a change of +61.8% over 9 years; net profit was positive in 3 of 10 reported years; operating margin moved from 9.7% to 5.3%, a shift of -4.4 percentage points; the most recent year shows a net loss of $232.0M.

Income Statement — 10 Years (USD millions)

Metric2016201720182019202020212022202320242025
Revenue$2.9B$2.9B$3.1B$3.1B$3.3B$4.8B$4.4B$4.4B$4.4B$4.7B
Operating Expenses$2.6B$2.7B$2.8B$2.7B$3.4B$4.5B$4.0B$4.1B$4.2B$4.5B
Operating Profit$283.0M$142.0M$314.0M$370.0M$-77.0M$304.0M$384.0M$326.0M$251.0M$252.0M
Operating Margin9.7%4.9%10.2%12.1%-2.4%6.4%8.7%7.4%5.7%5.3%
Other Income$-306.0M$-375.0M$-200.0M$-292.0M$-595.0M$-875.0M$-456.0M$-1.5B$237.0M$-476.0M
Interest$0$0$30.0M$79.0M$156.0M$264.0M$256.0M$277.0M$339.0M$220.0M
Depreciation$254.0M$318.0M$296.0M$315.0M$517.0M$716.0M$682.0M$694.0M$662.0M$680.0M
Profit Before Tax$-22.0M$-233.0M$114.0M$78.0M$-672.0M$-571.0M$-72.0M$-1.2B$488.0M$-224.0M
Tax$-113.8M$-33.6M$24.2M$13.2M$16.6M$15.4M$-8.3M$-3.0M$30.7M$-3.6M
Net Profit$-48.0M$-311.0M$87.0M$68.0M$-560.0M$-483.0M$-78.0M$-1.2B$338.0M$-232.0M
EPS$-0.13$-0.87$0.28$0.18$-1.27$-0.97$-0.15$-2.50$0.68$-0.47
Dividend Payout0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%

Quarterly Results — Last 12 Quarters (USD millions)

8 duplicate period labels in the source data were collapsed.

MetricSep '23Dec '23Mar '24Jun '24Sep '24Dec '24Mar '25Jun '25Sep '25Dec '25Mar '26Jun '26
Revenue$1.1B$1.0B$1.2B$1.2B$1.0B$1.0B$1.2B$1.2B$1.1B$1.1B$1.4B$1.4B
Operating Expenses$1.0B$1.0B$1.1B$1.1B$1.0B$1.0B$1.1B$1.2B$1.1B$1.1B$1.1B$1.3B
Operating Profit$42.0M$10.0M$133.0M$115.0M$-5.0M$8.0M$121.0M$85.0M$27.0M$19.0M$307.0M$109.0M
Operating Margin3.9%1.0%11.0%9.7%-0.5%0.8%10.1%6.8%2.4%1.7%22.4%8.0%
Interest$72.0M$67.0M$66.0M$65.0M$85.0M$62.0M$53.0M$70.0M$52.0M$91.0M$57.0M$59.0M
Profit Before Tax$-1.1B$-127.0M$12.0M$-32.0M$559.0M$-51.0M$60.0M$25.0M$-50.0M$-259.0M$87.0M$56.0M
Tax$90,000$-11.0M$-166.7M$-56.3M$34.9M$84.3M$-11.7M$56.0M$32.0M$-6.6M$34.5M$3.6M
Net Profit$-1.1B$-141.0M$32.0M$-50.0M$364.0M$-8.0M$67.0M$11.0M$-34.0M$-276.0M$57.0M$54.0M
EPS$-2.22$-0.29$0.06$-0.10$0.73$-0.02$0.13$0.02$-0.07$-0.55$0.11$0.11

Over the 10 years reported for Elanco Animal Health Incorporated, cash stood at $545.0M in the latest year, shareholders' equity was $0, current assets covered current liabilities 2.17 times.

Balance Sheet — 10 Years (USD millions)

Metric2016201720182019202020212022202320242025
Total Assets$8.1B$8.9B$9.0B$9.0B$17.7B$16.5B$15.5B$14.4B$12.6B$13.4B
Current Assets$1.9B$2.1B$2.5B$2.4B$3.4B$3.3B$3.3B$3.4B$3.2B$3.5B
Cash$259.0M$323.0M$475.0M$334.0M$495.0M$638.0M$345.0M$352.0M$468.0M$545.0M
Inventory$876.0M$1.1B$1.0B$1.1B$1.6B$1.4B$1.5B$1.7B$1.6B$1.7B
Receivables$631.0M$602.0M$709.0M$890.0M$1.1B$1.0B$1.0B$1.0B$886.0M$940.0M
Fixed Assets$742.0M$920.0M$922.0M$955.0M$1.3B$1.1B$999.0M$1.0B$993.0M$1.4B
Capital Work in Progress$0$0$0$0$0$0$0$0$0$0
Investments$9.0M$12.0M$15.0M$0$0$0$0$0$0$0
Other Assets$2.6B$3.0B$3.0B$3.0B$6.2B$6.2B$6.0B$5.1B$4.4B$4.8B
Total Liabilities$1.1B$1.1B$3.8B$3.4B$9.2B$9.0B$8.2B$8.1B$6.5B$6.8B
Current Liabilities$619.0M$633.0M$971.0M$819.0M$2.1B$1.6B$1.7B$1.2B$1.3B$1.6B
Borrowings$0$0$2.5B$2.4B$6.1B$6.3B$5.8B$5.8B$4.3B$4.0B
Other Liabilities$1.1B$1.1B$1.3B$1.1B$3.1B$2.7B$2.4B$2.4B$2.2B$2.8B
Equity$7.5B$8.0B$0$0$0$0$0$0$0$0
Reserves$7.0B$7.8B$5.2B$5.5B$8.5B$7.5B$7.3B$6.2B$6.1B$6.5B

For Elanco Animal Health Incorporated, operating cash flow was positive in 9 of 10 reported years; free cash flow in the latest year was $284.0M; free cash flow was positive in 9 of 10 years.

Cash Flow Statement — 10 Years (USD millions)

Metric2016201720182019202020212022202320242025
Operating Cash Flow$156.0M$174.0M$487.0M$224.0M$-41.0M$483.0M$452.0M$271.0M$541.0M$560.0M
Investing Cash Flow$-292.0M$-1.1B$-261.0M$-432.0M$-5.1B$-727.0M$-363.0M$-323.0M$1.0B$-555.0M
Financing Cash Flow$-150.0M$848.0M$-4.2B$-184.0M$-118.0M$33.0M$-32.0M$-6.0M$-17.0M$288.0M
Net Cash Flow$-202.0M$65.0M$354.0M$-332.0M$160.0M$132.0M$-293.0M$7.0M$116.0M$77.0M
Free Cash Flow$46.0M$75.0M$353.0M$27.0M$-352.0M$286.0M$268.0M$117.0M$394.0M$284.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.34
EV / EBITDA18.66
FCF Yield3.43%
Quick Ratio1.10
Interest Coverage1.78
Return 1Y14.20%
Return 3Y128.51%
Return 5Y-32.47%

Elanco Animal Health Incorporated (ELAN) financials — frequently asked questions

What is Elanco Animal Health Incorporated's annual revenue?

Elanco Animal Health Incorporated (ELAN) reported annual revenue of $4.7B in its most recent fiscal year.

What is Elanco Animal Health Incorporated's net profit?

Elanco Animal Health Incorporated (ELAN) reported a net loss of $232.0M in its most recent fiscal year.

What is ELAN EV/EBITDA?

Elanco Animal Health Incorporated's enterprise value to EBITDA (EV/EBITDA) ratio is 18.66.

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNYSE High ROE StocksAll stock screens
ELAN Overview ELAN Dividend Run Stock Screener

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.